Cellular mechanisms governing cross-presentation of exogenous antigens

Nature Immunology

Volumn 5, Issue 7, 2004, Pages 678-684

  Ackerman, Anne L ^a   Cresswell, Peter ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN BINDING; ANTIGEN PRESENTATION; CELL FUNCTION; CELL METABOLISM; CELL ORGANELLE; DENDRITIC CELL; ENDOPLASMIC RETICULUM; ENDOSOME; IN VIVO STUDY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; REVIEW; ANIMAL; CROSS PRESENTATION; ENDOCYTOSIS; HUMAN; IMMUNOLOGY; METABOLISM; PHAGOCYTOSIS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CROSS-PRIMING; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; HUMANS; PHAGOCYTOSIS;

EID: 3242804567     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1082     Document Type: Review

References (75)

1. Lankat-Buttgereit, B. & Tampe, R. The transporter associated with antigen processing: function and implications in human diseases. Physiol. Rev. 82, 187-204 (2002).
2. Serwold, T., Gonzalez, F., Kim, J., Jacob, R. & Shastri, N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419, 480-483 (2002).
3. York, I.A. et al. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3, 1177-1184 (2002).
4. Rock, K.L., York, I.A. & Goldberg, A.L. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat. Immunol. 5, 670-677 (2004).
5. Kloetzel, P.-M. Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nat. Immunol. 5, 661-669 (2004).
6. Radcliffe, C.M. et al. Identification of specific glycoforms of major histocompatibility complex class I heavy chains suggests that class I peptide loading is an adaptation of the quality control pathway involving calreticulin and ERp57. J. Biol. Chem. 277, 46415-45423 (2002).
7. Dick, T.P., Bangia, N., Peaper, D.R. & Cresswell, P. Disulfide bond isomerization and the assembly of MHC class I-peptide complexes. Immunity 16, 87-98 (2002).
8. Williams, A.P., Peh, C.A., Purcell, A.W., McCluskey, J. & Elliott, T. Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 16, 509-520 (2002).
9. Zarling, A.L. et al. Tapasin is a facilitator, not an editor, of class I MHC peptide binding. J. Immunol. 171, 5287-5295 (2003).
10. + T cells. Science 248, 1227-1230 (1990).
11. Garbi, N. et al. Impaired immune responses and altered peptide repertoire in tapasin-deficient mice. Nat. Immunol. 1, 234-238 (2000).
12. Grandea, A.G., 3rd et al. Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. Immunity 13, 213-222 (2000).
13. Lehner, P.J., Surman, M.J. & Cresswell, P. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220. Immunity 8, 221-231 (1998).
14. Gao, B. et al. Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin. Immunity 16, 99-109 (2002).
15. Hombach, J., Pircher, H., Tonegawa, S. & Zinkernagel, R.M. Strictly transporter of antigen presentation (TAP) dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein. J. Exp. Med. 182, 1615-1619 (1995).
16. Spies, T. & DeMars, R. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 351, 323-324 (1991).
17. Momburg, F. & Tan, P. Tapasin-the keystone of the loading complex optimizing peptide binding by MHC class I molecules in the endoplasmic reticulum. Mol. Immunol. 39, 217-233 (2002).
18. Mellman, I. & Steinman, R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 106, 255-258 (2001).
19. Sigal, L.J., Crotty, S., Andino, R. & Rock, K.L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398, 77-80 (1999).
20. Mueller, S.N., Jones, C.M., Smith, C.M., Heath, W.R. & Carbone, F.R. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J. Exp. Med. 195, 651-656 (2002).
21. Kaleab, B. et al. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Eur. J. Immunol. 20, 2651-2659 (1990).
22. Szalay, G., Hess, J. & Kaufmann, S.H. Presentation of Listeria monocytogenes antigens by major histocompatibility complex class I molecules to CD8 cytotoxic T lymphocytes independent of listeriolysin secretion and virulence. Eur. J. Immunol. 24, 1471-1477 (1994).
23. Romero, P. et al. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341, 323-326 (1989).
24. + cytotoxic T cell responses. Eur. J. Immunol. 24, 2813-2817 (1994).
25. Jones, C.A. et al. Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells in vitro. J. Virol. 77, 11139-11149 (2003).
26. Gredmark, S. & Soderberg-Naucler, C. Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions. J. Virol. 77, 10943-10956 (2003).
27. Bevan, M.J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143, 1283-1288 (1976).
28. Bevan, M.J. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J. Immunol. 117, 2233-2238 (1976).
29. - dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192, 1685-1696 (2000).
30. + dendritic cells. J. Immunol. 166, 5327-5330 (2001).
31. + dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J. Immunol. 170, 4437-4440 (2003).
32. Reis e Sousa, C. & Germain, R.N. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182, 841-851 (1995).
33. Rock, K.L. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17, 131-137 (1996).
34. Harding, C.V. & Song, R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153, 4925-4933 (1994).
35. Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B. & Rock, K.L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA 90, 4942-4946 (1993).
36. Fonteneau, J.F. et al. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood 102, 4448-4455 (2003).
37. Steinman, R.M., Inaba, K., Turley, S., Pierre, P. & Mellman, I. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum. Immunol. 60, 562-567 (1999).
38. Chefalo, P.J. & Harding, C.V. Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and acidic pH. J. Immunol. 167, 1274-1282 (2001).
39. Hewitt, E.W. et al. Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation. EMBO J. 21, 2418-2429 (2002).
40. Kleijmeer, M.J. et al. Antigen loading of MHC class I molecules in the endocytic tract. Traffic 2, 124-137 (2001).
41. Clayton, A. et al. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J. Immunol. Methods 247, 163-174 (2001).
42. -/- macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH. J. Immunol. 170, 5825-5833 (2003).
43. Kovacsovics-Bankowski, M. & Rock, K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267, 243-246 (1995).
44. Norbury, C.C., Hewlett, L.J., Prescott, A.R., Shastri, N. & Watts, C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 3, 783-791 (1995).
45. Rock, K.L., Rothstein, L., Fleischacker, C. & Gamble, S. Inhibition of class I and class II MHC-restricted antigen presentation by cytotoxic T lymphocytes specific for an exogenous antigen. J. Immunol. 148, 3028-3033 (1992).
46. Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P. & Amigorena, S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1, 362-368 (1999).
47. Wiertz, E.J. et al. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384, 432-438 (1996).
48. Pilon, M., Schekman, R. & Romisch, K. Sec61p mediates export of a misfolded secretory protein from the endoplasmic reticulum to the cytosol for degradation. EMBO J 16, 4540-4548 (1997).
49. McCracken, A.A. & Brodsky, J.L. Evolving questions and paradigm shifts in endoplasmic-reticulum-associated degradation (ERAD). Bioessays 25, 868-877 (2003).
50. Desjardins, M., Huber, L.A., Parton, R.G. & Griffiths, G. Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. J. Cell Biol. 124, 677-688 (1994).
51. Gagnon, E. et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110, 119-131 (2002).
52. Muller-Taubenberger, A. et al. Calreticulin and calnexin in the endoplasmic reticulum are important for phagocytosis. EMBO J. 20, 6772-6782 (2001).
53. Van den Berg, B. et al. X-ray structure of a protein-conducting channel. Nature 427, 36-44 (2004).
54. Hemmelder, M.H., de Jong, P.E. & de Zeeuw, D. A comparison of analytic procedures for measurement of fractional dextran clearances. J. Lab. Clin. Med. 132, 390-403 (1998).
55. Hughes, E.A., Hammond, C. & Cresswell, P. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. USA 94, 1896-1901 (1997).
56. Wiertz, E.J. et al. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84, 769-779 (1996).
57. Tirosh, B., Furman, M.H., Tortorella, D. & Ploegh, H.L. Protein unfolding is not a prerequisite for endoplasmic reticulum-to-cytosol dislocation. J. Biol. Chem. 278, 6664-6672 (2003).
58. Ye, Y., Meyer, H.H. & Rapoport, T.A. Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J. Cell Biol. 162, 71-84 (2003).
59. Huang, A.Y., Bruce, A.T., Pardoll, D.M. & Levitsky, H.I. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 4, 349-355 (1996).
60. Ackerman, A.L., Kyritsis, C., Tampe, R. & Cresswell, P. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc. Natl. Acad. Sci. USA 100, 12889-12894 (2003).
61. Guermonprez, P. et al. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425, 397-402 (2003).
62. Houde, M. et al. Phagosomes are competent organelles for antigen cross-presentation. Nature 425, 402-406 (2003).
63. Chow, A., Toomre, D., Garrett, W. & Mellman, I. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418, 988-994 (2002).
64. Boes, M. et al. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418, 983-988 (2002).
65. Ackerman, A.L. & Cresswell, P. Regulation of MHC class I transport in human dendritic cells and the dendritic-like cell line KG-1. J. Immunol. 170, 4178-4188 (2003).
66. MacAry, P.A. et al. Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells. Proc. Natl. Acad. Sci. USA 98, 3982-3987 (2001).
67. Lizee, G. et al. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat. Immunol. 4, 1065-1073 (2003).
68. + T lymphocytes. Cell 77, 525-535 (1994).
69. Lehner, P.J., Karttunen, J.T., Wilkinson, G.W. & Cresswell, P. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc. Natl. Acad. Sci. USA 94, 6904-6909 (1997).
70. Princiotta, M.F. et al. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18, 343-354 (2003). .
71. Reits, E.A., Vos, J.C., Gromme, M. & Neefjes, J. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404, 774-778 (2000).
72. Steinman, R.M., Brodie, S.E. & Cohn, Z.A. Membrane flow during pinocytosis. A stereologic analysis. J. Cell Biol. 68, 665-687 (1976).
73. Larsson, M. et al. Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. Eur. J. Immunol. 31, 3432-3442 (2001).
74. Freigang, S., Egger, D., Bienz, K., Hengartner, H. & Zinkernagel, R.M. Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming. Proc. Natl. Acad. Sci. USA 100, 13477-13482 (2003).
75. Ortmann, B. et al. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277, 1306-1309 (1997).